Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

185 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Multiple sclerosis characteristics in African American patients in the New York State Multiple Sclerosis Consortium.
Weinstock-Guttman B, Jacobs LD, Brownscheidle CM, Baier M, Rea DF, Apatoff BR, Blitz KM, Coyle PK, Frontera AT, Goodman AD, Gottesman MH, Herbert J, Holub R, Lava NS, Lenihan M, Lusins J, Mihai C, Miller AE, Perel AB, Snyder DH, Bakshi R, Granger CV, Greenberg SJ, Jubelt B, Krupp L, Munschauer FE, Rubin D, Schwid S, Smiroldo J; New York State Multiple Sclerosis Consortium. Weinstock-Guttman B, et al. Among authors: goodman ad. Mult Scler. 2003 Jun;9(3):293-8. doi: 10.1191/1352458503ms909oa. Mult Scler. 2003. PMID: 12814178
A profile of multiple sclerosis: the New York State Multiple Sclerosis Consortium.
Jacobs LD, Wende KE, Brownscheidle CM, Apatoff B, Coyle PK, Goodman A, Gottesman MH, Granger CV, Greenberg SJ, Herbert J, Krupp L, Lava NS, Mihai C, Miller AE, Perel A, Smith CR, Snyder DH. Jacobs LD, et al. Mult Scler. 1999 Oct;5(5):369-76. doi: 10.1177/135245859900500511. Mult Scler. 1999. PMID: 10516782
Rapid disease course in African Americans with multiple sclerosis.
Kister I, Chamot E, Bacon JH, Niewczyk PM, De Guzman RA, Apatoff B, Coyle P, Goodman AD, Gottesman M, Granger C, Jubelt B, Krupp L, Lenihan M, Lublin F, Mihai C, Miller A, Munschauer FE 3rd, Perel AB, Teter BE, Weinstock-Guttman B, Zivadinov R, Herbert J. Kister I, et al. Among authors: goodman ad. Neurology. 2010 Jul 20;75(3):217-23. doi: 10.1212/WNL.0b013e3181e8e72a. Neurology. 2010. PMID: 20644149
The measurement of ambulatory impairment in multiple sclerosis.
Schwid SR, Goodman AD, Mattson DH, Mihai C, Donohoe KM, Petrie MD, Scheid EA, Dudman JT, McDermott MP. Schwid SR, et al. Among authors: goodman ad. Neurology. 1997 Nov;49(5):1419-24. doi: 10.1212/wnl.49.5.1419. Neurology. 1997. PMID: 9371932
Dose comparison trial of sustained-release fampridine in multiple sclerosis.
Goodman AD, Brown TR, Cohen JA, Krupp LB, Schapiro R, Schwid SR, Cohen R, Marinucci LN, Blight AR; Fampridine MS-F202 Study Group. Goodman AD, et al. Neurology. 2008 Oct 7;71(15):1134-41. doi: 10.1212/01.wnl.0000326213.89576.0e. Epub 2008 Jul 30. Neurology. 2008. PMID: 18672472 Clinical Trial.
185 results